Sign up to save your podcasts
Or
Share Relapsed/Refractory Follicular Lymphoma Part 1 — A Roundtable Discussion on the Selection and Sequencing of Bispecific Antibodies
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Relapsed/Refractory Follicular Lymphoma Part 1 — A Roundtable Discussion on the Selection and Sequencing of Bispecific Antibodies
Dr Carla Casulo from Wilmot Cancer Institute in Rochester, New York, Dr Matthew Matasar from Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Laurie H Sehn from BC Cancer Centre for Lymphoid Cancer in Vancouver discuss recent updates on available and novel treatment strategies for relapsed/refractory follicular lymphoma.
CME information and select publications here.
View all episodes
By Dr. Neil Love
4.4
6969 ratings
Dr Carla Casulo from Wilmot Cancer Institute in Rochester, New York, Dr Matthew Matasar from Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Laurie H Sehn from BC Cancer Centre for Lymphoid Cancer in Vancouver discuss recent updates on available and novel treatment strategies for relapsed/refractory follicular lymphoma.
CME information and select publications here.
More shows like Hematologic Oncology Update
View all
JAMA Editors' Summary
129 Listeners
Gastrointestinal Cancer Update
17 Listeners
Lung Cancer Update
31 Listeners
Prostate Cancer Update
15 Listeners
Breast Cancer Update
63 Listeners
Gynecologic Oncology Update
11 Listeners
Dermatologic Oncology Update
0 Listeners
NEJM This Week
315 Listeners
Research To Practice | Oncology Videos
115 Listeners
The Hematologist
28 Listeners
JAMA Clinical Reviews
485 Listeners
Annals On Call Podcast
184 Listeners
Blood Podcast
51 Listeners
Oncology Today with Dr Neil Love
53 Listeners
WolverHeme Happy Hour
29 Listeners
Two Onc Docs
166 Listeners
Blood Cancer Talks
48 Listeners